Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single cell transcriptome analysis of TIL for gene expression and TCR immunoprofiling in the renal cell carcinoma

ABSTRACT: Unlike other carcinomas, renal cell carcinoma is known to have an inverse correlation between the abundance of T cells in the tumor and prognosis. To elucidate the background, we performed single-cell gene expression analysis and TCR immunoprofiling of tumor-infiltrating T cells in early and advanced stages of renal cancer.

ORGANISM(S): Homo sapiens

PROVIDER: GSE304262 | GEO | 2026/02/18

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	GSE304262_KID_ALL_barcodes.tsv.gz	Tabular
	GSE304262_KID_ALL_features.tsv.gz	Tabular
	GSE304262_KID_ALL_matrix.mtx.gz	Other
	GSE304262_cell_metadata.csv.gz	Csv

Items per page:

1 - 5 of 5

Similar Datasets

Renal Cell Carcinoma

Project description:Renal cell carcinoma comprises several histological types with different clinical behavior. Accurate pathological characterization is important in the clinical management of these tumors. We describe gene expression profiles in 41 renal tumors determined by using DNA microarrays containing 22,648 unique cDNAs representing 17,083 different UniGene Clusters, including 7230 characterized human genes. Differences in the patterns of gene expression among the different tumor types were readily apparent; hierarchical cluster analysis of the tumor samples segregated histologically distinct tumor types solely based on their gene expression patterns. Conventional renal cell carcinomas with clear cells showed a highly distinctive pattern of gene expression. Papillary carcinomas formed a tightly clustered group, as did tumors arising from the distal nephron and the normal kidney samples. Surprisingly, conventional renal cell carcinomas with granular cytoplasm were heterogeneous, and did not resemble any of the conventional carcinomas with clear cytoplasm in their pattern of gene expression. Characterization of renal cell carcinomas based on gene expression patterns provides a revised classification of these tumors and has the potential to supply significant biological and clinical insights. A disease state experiment design type is where the state of some disease such as infection, pathology, syndrome, etc is studied. Computed

2006-01-31 | E-GEOD-4125 | biostudies-arrayexpress

Renal Cell Carcinoma

2006-02-01 | GSE4125 | GEO

Transcription profiling of human renal cell carcinoma

Project description:Materials and Methods Results Discussion References Renal cell carcinoma comprises several histological types with different clinical behavior. Accurate pathological characterization is important in the clinical management of these tumors. We describe gene expression profiles in 41 renal tumors determined by using DNA microarrays containing 22,648 unique cDNAs representing 17,083 different UniGene Clusters, including 7230 characterized human genes. Differences in the patterns of gene expression among the different tumor types were readily apparent; hierarchical cluster analysis of the tumor samples segregated histologically distinct tumor types solely based on their gene expression patterns. Conventional renal cell carcinomas with clear cells showed a highly distinctive pattern of gene expression. Papillary carcinomas formed a tightly clustered group, as did tumors arising from the distal nephron and the normal kidney samples. Surprisingly, conventional renal cell carcinomas with granular cytoplasm were heterogeneous, and did not resemble any of the conventional carcinomas with clear cytoplasm in their pattern of gene expression. Characterization of renal cell carcinomas based on gene expression patterns provides a revised classification of these tumors and has the potential to supply significant biological and clinical insights.

2005-10-05 | E-SMDB-1890 | biostudies-arrayexpress

Renal Cell Carcinoma: Hypoxia and Endocytosis

Project description:Hypoxia signature in Clear cell RCC A set of clear cell renal cell carcinomas were examined for the deregulation of hypoxia inducible and endocytosis regulated genes Tumor samples and Normal renal tissue GSE14762.rda contains an R data object

2009-02-09 | E-GEOD-14762 | biostudies-arrayexpress

Chromophobe renal cell carcinoma versus renal oncocytoma: a proteomic approach

Project description:The proteome of clinical tissue samples diagnosed with chromophobe renal cell carcinomas (chRCC) and renal oncocytomas (RO) were evaluated to establish a potential discriminative biomarker panel of proteins for these two tumors subtypes.

2024-01-26 | PXD022018 | Pride

Immunoprofiling of Darier Disease patients

Project description:Immunoprofiling of Darier Disease patients

| PRJNA917428 | ENA

Immunoprofiling of prostate cancer infiltrate

Project description:Immunoprofiling of prostate cancer infiltrate

| PRJNA644438 | ENA

Proteome profilling of chromophobe renal cell carcinomas

Project description:LC-MS/MS based proteomics study of chromophobe renal cell carcinomas versus the adjacent healthy kidney tissues, nine patients included. The chromophobe renal cell carcinoma cells (UOK276) under different conditions were also analyzed.

2020-07-23 | PXD019123 | Pride

Immunoprofiling of mouse prostate cancer infiltrate

Project description:Immunoprofiling of mouse prostate cancer infiltrate

| PRJNA958227 | ENA

Immunoprofiling of Darier Disease patients

Project description:Darier disease (DD) is a rare, inherited multi-organ disorder associated with mutations in the ATP2A2 gene. In DD patients, the skin is frequently affected, characterized by malodorous, inflamed skin and recurrent, severe infections. Therapeutic options are limited and inadequate for the long-term management of this chronic disease. Using immunoprofiling with NanoString technology we demonstrate enhanced expression of Th-17-related genes and cytokines in five DD patients. We prove that targeting the IL-23/-17 axis in DD with monoclonal antibodies is an effective and safe therapy in DD patients, leading also to significant clinical improvement.

2023-09-23 | GSE222043 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data